Treatment of Hepatitis C in Hemophilic Patients With HIV

NCT00055341 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Hepatitis C
Hemophilia

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Ribavirin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)